Cresco Labs (CSE: CL) (OTCQX: CRLBF) - Investor Dashboard

➔ Cresco Labs
CSE Ticker: CL
Sector: Healthcare
Industry: CPG
Country: Canada/U.S.
Employees: 550 as of 03/1/19
Established: 2013
CEO: Charles Bachtell


Fiscal Year-End: December
Auditor: MNP LLP
Exchanges: CSE, OTCQX
Sector:  Healthcare
States: 11
Headquarters: Chicago, IL

Financials (Pro Forma 9/30/18)

Cash on hand: $174.0 million
Fixed Investment: $19.3 million
Shareholders’ Equity: $357.1 million
Revenues – Last Quarter: $12.7 million
Adj. Gross Margin : 42.7%
EPS : n/a

Capital Structure (03/11/19)

Last Financing: 12.6 million shares at C$8.50
Shares: 270.1 million
Warrants: 4.4 million
Options: 20 million
Diluted Shares: 294.6 million

Company Brief

Cresco Labs (CSE: CL) (OTCQX: CRLBF), based in Chicago, is a leading U.S. cannabis company with experienced management, access to capital and a demonstrated growth strategy. As a differentiated grower, processor and retailer of premium cannabis with operations in nine states, the company focuses on entering markets with outsized demand potential, significant supply constraints and high barriers to entry.

Its unparalleled speed-to-market gives Cresco a distinct competitive advantage as it replicates its model to expand its national footprint. Cresco’s proven ability to execute is complemented by a well-defined brand strategy that is tailored to all major consumer segments: everyday cannabis, medicinally focused, connoisseur grade, and chef-inspired edibles by James Beard Award-winning pastry chef Mindy Segal.

Featured Video

A Multi-Brand approach to address variant consumer groups


  • Five brands to address variant consumer groups: Remedi, Cresco, Reserve, Mindy’s, and Mindy’s Kitchen
  • Strong medical advisory board and R&D partnerships with leading institutions and universities
  • More than 20 retail licenses and 23 production facilities
  • More than 5,000 SKUs in production
  • Current operations in Illinois, Pennsylvania, Ohio, Nevada, Arizona, Florida, and California; Pending regulatory approval in New York, Massachusetts, Michigan, and Maryland

Growth Strategy

  • Targeting expansion in states like Florida, New Jersey, Virginia, and Connecticut
  • Expanding into Michigan with planned cultivation and production facility; two dispensary applications pending
  • Create licensing and/or distribution partnerships to expand Mindy Segal edible products into growing markets such as Colorado, Oregon, Washington, Oklahoma, and New Mexico
  • CPG approach to building brands
  • Marketing strategy driven by awareness and education, in-store experience, and outreach
  • Formation of CBD subsidiary WellBeings
  • Actively pursuing the acquisition of licenses and existing cannabis operations


  • Cresco is one of a very small group of operators to successfully obtain cultivation licenses in more than one of the modern, limited license, merit-based application state programs
  • Cresco’s laboratory gives it the ability to formulate and develop a variety of products based on traditional pharmaceutical delivery systems – pills, tinctures, topical salves, transdermal patches and edible forms with a variety of cannabinoid profiles
  • One of the largest, vertically integrated multi-state operators

Curated Stories & News

Visit Cresco Labs, Inc.

New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. Cresco Labs, Inc. is a client of NCV Media, LLC. Read our full disclaimer.